Metastasis in Ovarian Cancer Traced to Newly Discovered Signaling Pathway

Metastasis in Ovarian Cancer Traced to Newly Discovered Signaling Pathway
Researchers at Cold Spring Harbor Laboratory (CSHL) published findings that highlight the discovery of a new cancer signaling pathway that may prove useful in the efforts to prevent metastasis in ovarian cancer (OC). The study, “HGF-independent regulation of MET and GAB1 by nonreceptor tyrosine kinase FER potentiates metastasis in ovarian cancer,” was published in the latest edition of

Knowledge is power when living with ovarian cancer.

Get access to the web’s leading Ovarian Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.
Kara Elam is currently working on her Doctorate in Health Policy. She holds Master Degrees in both epidemiology and microbiology. Her research interests include emerging viral diseases, the intersection of human rights and intellectual property rights, and ending violence against women.

Leave a Comment

Your email address will not be published. Required fields are marked *